How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?
Cleland
J G
JG
Department of Medicine (Cardiology), Royal Postgraduate Medical School, Hammersmith Hospital, London.
Puri
S
S
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D006332:Cardiomegaly / Q000188:drug therapy / Q000517:prevention & control; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000517:prevention & control; D009203:Myocardial Infarction / Q000150:complications / Q000503:physiopathology
D000806:Angiotensin-Converting Enzyme Inhibitors